Racial and ethnic differences in advanced-stage prostate cancer: The prostate cancer outcomes study

Journal of the National Cancer Institute

Volumn 93, Issue 5, 2001, Pages 388-395

  Hoffman, Richard M ^a,b   Gilliland, Frank D ^c   Eley, J William ^d   Harlan, Linda C ^e   Stephenson, Robert A ^f   Stanford, Janet L ^g,h   Albertson, Peter C ⁱ   Hamilton, Ann S ^b   Hunt, W Curtis ^b   Potosky, Arnold L ^f  

^a VA Medical Center   (United States)

^b UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d EMORY UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CANCER STAGING; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; EDUCATION; EMPLOYMENT; ETHNIC DIFFERENCE; ETHNIC GROUP; ETHNOLOGY; EVALUATION; HEALTH INSURANCE; HUMAN; INCOME; INFORMATION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL RECORD; OUTCOMES RESEARCH; PATHOLOGY; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; RACE; RACE DIFFERENCE; REGRESSION ANALYSIS; SOCIOECONOMICS; URINARY DYSFUNCTION;

EID: 0035819936     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.5.388     Document Type: Article

References (49)

1. Cancer statistics, 2000
2. Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
3. Racial differences in adenocarcinoma of the prostate in North American men
4. Risk factors for prostate cancer
5. Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes Study
6. Predictions of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging
7. Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term followup
8. Prostate specific antigen in the diagnosis and treatment of adeno-carcinoma of the prostate. I. Untreated patients
9. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
10. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994
11. Increasing incidence of cancer of the prostate. The experience of black and white men in the Detroit metropolitan area
12. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system
13. Stage at presentation and survival of white and black patients with prostate carcinoma
14. Removal of the financial barrier to health care: Does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system
15. Demographic differences in prostate cancer incidence and stage: An examination of population diversity in California
16. Stage at diagnosis of prostate cancer in Connecticut by poverty and race
17. Black versus white racial differences in clinical stage at diagnosis and treatment of prostatic cancer in Connecticut
18. Black-white differences in the stage at presentation of prostate cancer in the District of Columbia
19. Prostate cancer: The stage disadvantage in the black male
20. The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment
21. Prostate cancer incidence and mortality rates among white and black men
22. The National Cancer Data Base report on prostate cancer
23. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987
24. Black-white differences in stage-specific cancer survival: Analysis of seven selected sites
25. Is race an independent prognostic factor for survival from prostate cancer?
26. Socioeconomic factors and cancer incidence among blacks and whites
27. Rural-urban differences in stage at diagnosis. Possible relationship to cancer screening
28. Cancer in socioeconomically disadvantaged populations
29. Race, socioeconomic status, and other prognostic factors for survival from prostate cancer
30. Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms
31. Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer
32. A successful recruitment process of African American men for early detection of prostate cancer
33. Treatment options, selection, and satisfaction among African American and white men with prostate carcinoma in North Carolina
34. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening
35. Attitudes of African Americans regarding screening for prostate cancer
36. Race and the histologic grade of prostate cancer
37. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males
38. Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens
39. Keynote address: Prostate cancer among African-American men-from the bench to the community
40. Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada
41. A unifying model to explain the increased incidence and higher mortality of prostate cancer in black men
42. Dietary factors and risks for prostate cancer among blacks and whites in the United States
43. Early detection of prostate cancer and use of transrectal ultrasound
44. American Cancer Society guidelines for the early detection of cancer
45. Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute
46. European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies